Fig. 3From: Immunologic responses to the third and fourth doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in cell therapy recipients: a systematic review and meta-analysisForest plot of seroconversion after fourth dose in HSCT recipientsBack to article page